Skip to main content

Personalised Medicine in Public Healthcare Systems

  • Chapter
  • First Online:
Personalized Medicine in Healthcare Systems

Part of the book series: Europeanization and Globalization ((EAG,volume 5))

  • 691 Accesses

Abstract

This chapter discusses the profound impact personalised medicine is expected to have on public healthcare systems. First, introducing personalised medicine will radically affect the healthcare value chain and stages in which the healthcare system plays the key role, namely in the form of lifelong care for a person’s healthy life. Public healthcare networks will become increasingly international. Second, in the current situation, out-of-pocket payment is the most reasonable way of financing personalised medicine, but the future development of personalised medicine will depend on health insurance that resembles life insurance. Third, it is possible to ground collective financing only on solidarity and not on the differences between social and individual effects. Fourth, personalised medicine requires a great deal of state regulation. Fifth, personalised medicine is based on a large volume of information and only the individual should have the right to decide how this information is used.

This chapter addresses the relationship between personalised medicine and the public healthcare system. It is based on the hypothesis that the development of personalised medicine will call for a radical change in the foundations of public healthcare systems across the world.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Redekop and Mladsi (2013) and Jain (2015).

  2. 2.

    Jain (2015).

  3. 3.

    Official Journal of the European Union, 2015/C 421/03.

  4. 4.

    Jain (2015).

  5. 5.

    Carlsten et al. (2014).

  6. 6.

    Bieber (2013).

  7. 7.

    Jakka and Rossbach (2013).

  8. 8.

    Jakka and Rossbach (2013).

  9. 9.

    Jain (2015).

  10. 10.

    Meulen et al. (2001), Kornai and Eggleston (2001) and Saltman (2015).

  11. 11.

    Phelps (2016) and McPake et al. (2013).

  12. 12.

    Sagan and Thomson (2016).

  13. 13.

    Kornai (1986).

  14. 14.

    Jegers et al. (2002) and Phelps (2016).

  15. 15.

    Stiglitz and Rosengard (2015) and Carande-Kulis et al. (2007).

  16. 16.

    Henke and Borchardt (2003).

  17. 17.

    Jakka and Rossbach (2013).

  18. 18.

    Porter and Lee (2013).

  19. 19.

    Xinghua Hu et al. (2005).

  20. 20.

    McPake et al. (2013).

References

  • Bieber T (2013) Stratified medicine: a new challenge for academia, industry, regulators and patients. Future Medicine Ltd, London

    Book  Google Scholar 

  • Carande-Kulis VG, Getzen TE, Thacker SB (2007) Public goods and externalities: a research agenda for public health economics. J Public Health Man 13(2):227–232

    Google Scholar 

  • Carlsten C, Brauer M, Brinkman F, Brook J, Daley D, McNagny K, Pui M, Royce D, Takaro T, Denburg J (2014) Genes, the environment and personalized medicine: we need to harness both environmental and genetic data to maximize personal and population health. EMBO Rep 15(7):736–739

    Article  Google Scholar 

  • Council conclusions on personalised medicine for patients (2015) Official Journal of the European Union, 2015/C421/03

    Google Scholar 

  • Henke KD, Borchardt K (2003) Reform proposals for health-care systems. Dice Report 3:3–8

    Google Scholar 

  • Jain KK (2015) Textbook of personalized medicine. Humana Press, Basel

    Book  Google Scholar 

  • Jakka S, Rossbach M (2013) An economic perspective on personalized medicine. HUGO J 7(1)

    Article  Google Scholar 

  • Jegers M, Kesteloot K, De Graeve D, Gilles W (2002) A typology for provider payment systems in health care. Health Policy 60(3):255–273

    Article  Google Scholar 

  • Kornai J (1986) The soft budget constraint. Kyklos 39(1):3–30

    Article  Google Scholar 

  • Kornai J, Eggleston K (2001) Welfare, choice, and solidarity in transition. Cambridge University Press, Cambridge

    Book  Google Scholar 

  • McPake B, Normand C, Smith S (2013) Health economics: an international perspective. Routledge, Abingdon

    Book  Google Scholar 

  • Meulen R, Arts W, Muffels R (2001) Solidarity, health and social care in Europe: introduction to the volume. In: Meulen R, Arts W, Muffels R (eds) Solidarity in health and social care in Europe. Kluwer, Dordrecht, pp 1–11

    Chapter  Google Scholar 

  • Phelps CE (2016) Health economics, 5th edn. Routledge, New York

    Book  Google Scholar 

  • Porter ME, Lee TH (2013) The strategy that will fix health care. Harv Bus Rev 91(10)

    Google Scholar 

  • Redekop WK, Mladsi D (2013) The faces of personalized medicine: a framework for understanding its meaning and scope. Value Health 16(6 Suppl):S4–S9

    Article  Google Scholar 

  • Sagan A, Thomson S (2016) Voluntary health insurance in Europe: role and regulation. World Health Organization, European Observatory on Health Systems and Policies, Copenhagen

    Google Scholar 

  • Saltman RB (2015) Health sector solidarity: a core European value but with broadly varying content. Isr J Health Policy Res 4(5)

    Google Scholar 

  • Stiglitz JE, Rosengard JK (2015) Economics of the public sector, 4th edn. W.W. Norton, cop., New York, London

    Google Scholar 

  • Xinghua Hu S, Foster T, Kieffaber A (2005) Pharmacogenomics and personalized medicine: mapping of future value creation. BioTechniques 39(4)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Petra Došenović Bonča .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tajnikar, M., Došenović Bonča, P. (2019). Personalised Medicine in Public Healthcare Systems. In: Bodiroga-Vukobrat, N., Rukavina, D., Pavelić, K., Sander, G.G. (eds) Personalized Medicine in Healthcare Systems. Europeanization and Globalization, vol 5. Springer, Cham. https://doi.org/10.1007/978-3-030-16465-2_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-16465-2_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-16464-5

  • Online ISBN: 978-3-030-16465-2

  • eBook Packages: Law and CriminologyLaw and Criminology (R0)

Publish with us

Policies and ethics